English  |  正體中文  |  简体中文  |  總筆數 :2856704  
造訪人次 :  53699083    線上人數 :  2020
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"yu chong jen"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 61-70 / 489 (共49頁)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-05-05T05:32:31Z Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1 Chung, Kuei-Pin; Huang, Yen-Lin; Chen, Yi-Jung; Juan, Yi-Hsiu; Hsu, Chia-Lang; Nakahira, Kiichi; Huang, Yen-Tsung; Lin, Mong-Wei; SHANG-GIN WU; Shih, Jin-Yuan; Chang, Yih-Leong; Yu, Chong-Jen
臺大學術典藏 2021-05-05T05:28:58Z The effectiveness of afatinib in patients with lung adenocarcinoma harboring complex epidermal growth factor receptor mutation Shang-Gin Wu;Yu, Chong-Jen;Yang, James Chih-Hsin;Shih, Jin-Yuan; SHANG-GIN WU; Yu, Chong-Jen; Yang, James Chih-Hsin; Shih, Jin-Yuan
臺大學術典藏 2021-05-02T02:18:53Z Completion and Adverse Drug Events of Latent Tuberculosis Infection Treatment in Patients Receiving Dialysis: Predictors and Impacts of Different Regimens in a Prospective Cohort Study Lin, Shu-Yung; Feng, Jia-Yih; Lee, Chih-Yuan; Lin, Yi-Chih; YU-HSIANG CHOU; Lin, Kuan-Yin; Wei, Yu-Feng; Lin, Shu-Wen; Chang, Chin-Hao; Wang, Ping-Huai; Shu, Chin-Chung; Wang, Jann-Yuan; Yu, Chong-Jen
臺大學術典藏 2021-05-02T02:11:38Z Completion and Adverse Drug Events of Latent Tuberculosis Infection Treatment in Patients Receiving Dialysis: Predictors and Impacts of Different Regimens in a Prospective Cohort Study Lin, Shu-Yung; Feng, Jia-Yih; Lee, Chih-Yuan; Lin, Yi-Chih; Chou, Yu-Hsiang; Lin, Kuan-Yin; Wei, Yu-Feng; Lin, Shu-Wen; Chang, Chin-Hao; Wang, Ping-Huai; Shu, Chin-Chung; Wang, Jann-Yuan; Yu, Chong-Jen
臺大學術典藏 2021-03-10T06:39:30Z Matrix Metalloprotease-7 Mediates Nucleolar Assembly and Intra-nucleolar Cleaving p53 in Gefitinib-Resistant Cancer Stem Cells WEI-HSUAN YU; Wu, Erxi; Li, Yongqing; Hou, Hsin-Han; Yu, Shuan-Su C; Huang, Po-Tsang; Kuo, Wen-Hung; Qi, Dan; Yu, Chong-Jen
臺大學術典藏 2021-02-08T08:05:10Z Effect of beta-Blocker in Treatment-Naive Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIs JEN-CHUNG KO; CHIA-HAO CHANG; LIH-YU CHANG; Lee, Chih-Hsin ; Lee, Ming-Chia ; Zhang, Jun-Fu ; Wang, Jann-Yuan ; Shih, Jin-Yuan ; Yu, Chong-Jen
臺大學術典藏 2020-11-11T08:37:03Z The impact on incident tuberculosis by kidney function impairment status: analysis of severity relationship Cheng, Shih-Lung; Wang, Jann-Yuan; Yu, Chong-Jen; Wang, Ping-Huai; Chen, Chung-Yu; Yeh, Yi-Chun; HSIEN-HO LIN; Shu, Chin-Chung; Wei, Yu-Feng; Shu, Chin-Chung;Wei, Yu-Feng;Yeh, Yi-Chun;Hsien-Ho Lin;Chen, Chung-Yu;Wang, Ping-Huai;Cheng, Shih-Lung;Wang, Jann-Yuan;Yu, Chong-Jen
臺大學術典藏 2020-02-10T09:00:24Z Prior EGFR tyrosine-kinase inhibitor therapy did not influence the efficacy of subsequent pemetrexed plus platinum in advanced chemona?ve patients with EGFR-mutant lung adenocarcinoma MONG-HSUN TSAI; Chang, Gee-Chen; Chen, Hsuan-Yu; Chen, Jeremy Jw; Su, Kang-Yi; Yu, Sung-Liang; Tsai, Meen-Hsin; Tseng, Jeng-Sen; Yang, Tsung-Ying; Chen, Kun-Chieh; Hsu, Kuo-Hsuan; Yu, Chong-Jen; Liao, Wei-Yu; Tsai, Chi-Ren
臺大學術典藏 2020-02-10T09:00:22Z EGFR mutation, smoking, and gender in advanced lung adenocarcinoma Tseng, Chien-Hua; Chiang, Chun-Ju; Tseng, Jeng-Sen; Yang, Tsung-Ying; Hsu, Kuo-Hsuan; Chen, Kun-Chieh; Wang, Chih-Liang; Chen, Chih-Yi; Yen, Sang-Hue; Tsai, Chun-Ming; Huang, Ming-Shyan; Ho, Chao-Chi; Yu, Chong-Jen; Tsai, Ying-Huang; Chen, Jin-Shing; Chou, Teh-Ying; Tsai, Ming-Hsun; Chen, Hsuan-Yu; Su, Kang-Yi; Chen, Jeremy J. W.; Chen, Huei-Wen; Yu, Sung-Liang; Liu, Tsang-Wu; Chang, Gee-Chen; MONG-HSUN TSAI
臺大學術典藏 2019-12-19T08:05:13Z Non-small cell lung cancer harbouring non-resistant uncommon EGFR mutations: Mutation patterns, effectiveness of epidermal growth factor receptor-tyrosine kinase inhibitors and prognostic factors LIH-YU CHANG; Chang, Lih-Chyun; Lim, Chor-Kuan; Chen, Kuan-Yu; Shih, Jin-Yuan; Yu, Chong-Jen

顯示項目 61-70 / 489 (共49頁)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
每頁顯示[10|25|50]項目